HUP9802329A2 - Karbonsavszármazékok - Google Patents

Karbonsavszármazékok

Info

Publication number
HUP9802329A2
HUP9802329A2 HU9802329A HUP9802329A HUP9802329A2 HU P9802329 A2 HUP9802329 A2 HU P9802329A2 HU 9802329 A HU9802329 A HU 9802329A HU P9802329 A HUP9802329 A HU P9802329A HU P9802329 A2 HUP9802329 A2 HU P9802329A2
Authority
HU
Hungary
Prior art keywords
phenyl
naphthyl
alkyl
halogen
substituted
Prior art date
Application number
HU9802329A
Other languages
English (en)
Inventor
Wilhelm Amberg
Bernd Elger
Stefan Hergenröder
Andreas Kling
Dagmar Klinge
Manfred Raschack
Hartmut Riechers
Sabine Schult
Liliane Unger
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of HUP9802329A2 publication Critical patent/HUP9802329A2/hu
Publication of HUP9802329A3 publication Critical patent/HUP9802329A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

A találmány endőthelin receptőr antagőnista (I) általánősképletű vegyületekre vőnatkőzik, amelyek képletében R1 tetrazőlil-, cianő-, karbőxilcsőpőrt, vagy egy karbőxilcsőpőrttáhidrőlizálható csőpőrt, R2 és R3 azőnősan vagy egymástól eltérően adőtt esetben halőgénatőmmal,cianő-, nitrő-, hidrőxi-, alkil-, halőgén-alkil-, alkőxi-, halőgén-alkőxi-, fenőxi-, alkil-tiő-, aminő-, benzil-őxi-, alkil-aminő-és/vagy dialkil-aminő-csőpőrttal szűbsztitűált fenil- vagynaftilcsőpőrt, vagy fenil- vagy naftilcsőpőrt, amely őrtő helyzetbenközvetlen kötésen, metilén-, etilén- vagy vinilcsőpőrtőn keresztül egyőxigén- vagy kénatőmhőz kapcsőlódik, R4 adőtt esetben szűbsztitűált fenil, naftil, (metilén-diőxi)-fenil-,(etilén-diőxi)-fenil-, indanil-, indőlil-, piridil-, benzőpiranil-,fűril-, benzőfűril-, izőxazőlil-, izőtiazőlil-, 1,3,4-tiadiazőlil-,pirimidinil-, 2,3-dihidrőbenzőfűril-, benzőtienil-, kinőlil-,ciklőalkil-, tienil-, őxazőlil- vagy tiazőlilcsőpőrt, R5 adőtt esetben szűbsztitűált alkil-, alkenil-, alkinil-, ciklőalkil-,fenil-, benzil-, 1-metil-naftil-, 2-metil-naftil- vagy naftilcsőpőrt,és n 1 vagy 2. ŕ
HU9802329A 1995-09-07 1996-08-29 Carboxylic acid derivatives HUP9802329A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19533025A DE19533025A1 (de) 1995-09-07 1995-09-07 Neue Carbonsäurederivate, ihre Herstellung und Verwendung

Publications (2)

Publication Number Publication Date
HUP9802329A2 true HUP9802329A2 (hu) 1999-02-01
HUP9802329A3 HUP9802329A3 (en) 1999-04-28

Family

ID=7771490

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802329A HUP9802329A3 (en) 1995-09-07 1996-08-29 Carboxylic acid derivatives

Country Status (30)

Country Link
US (1) US6004988A (hu)
EP (1) EP0862550B1 (hu)
JP (1) JPH11512104A (hu)
KR (1) KR19990044455A (hu)
CN (1) CN1070841C (hu)
AR (1) AR003532A1 (hu)
AT (1) ATE197448T1 (hu)
AU (1) AU705956B2 (hu)
BG (1) BG63720B1 (hu)
BR (1) BR9610139A (hu)
CA (1) CA2228002A1 (hu)
CO (1) CO5040228A1 (hu)
CZ (1) CZ64198A3 (hu)
DE (2) DE19533025A1 (hu)
ES (1) ES2153124T3 (hu)
GR (1) GR3034797T3 (hu)
HR (1) HRP960400B1 (hu)
HU (1) HUP9802329A3 (hu)
IL (1) IL123213A (hu)
MY (1) MY132151A (hu)
NO (1) NO310651B1 (hu)
NZ (1) NZ316940A (hu)
PL (1) PL325398A1 (hu)
PT (1) PT862550E (hu)
RU (1) RU2175315C2 (hu)
SI (1) SI0862550T1 (hu)
SK (1) SK282082B6 (hu)
TR (1) TR199800410T1 (hu)
WO (1) WO1997009294A1 (hu)
ZA (1) ZA967537B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
WO2004046104A2 (en) 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224572C2 (de) * 1992-07-24 1996-04-18 Sfs Ind Holding Ag Befestigungselement zum Einsatz in Beton oder dgl. Material
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists

Also Published As

Publication number Publication date
DE19533025A1 (de) 1997-03-13
BG102347A (en) 1999-03-31
CA2228002A1 (en) 1997-03-13
ES2153124T3 (es) 2001-02-16
HRP960400B1 (en) 2001-08-31
DE59606132D1 (de) 2000-12-14
CN1200720A (zh) 1998-12-02
RU2175315C2 (ru) 2001-10-27
PL325398A1 (en) 1998-07-20
PT862550E (pt) 2001-03-30
KR19990044455A (ko) 1999-06-25
CO5040228A1 (es) 2001-05-29
NO981002D0 (no) 1998-03-06
IL123213A0 (en) 1998-09-24
CZ64198A3 (cs) 1998-09-16
GR3034797T3 (en) 2001-02-28
HRP960400A2 (en) 1998-04-30
ATE197448T1 (de) 2000-11-11
SK282082B6 (sk) 2001-10-08
MY132151A (en) 2007-09-28
ZA967537B (en) 1998-03-06
IL123213A (en) 2000-11-21
BR9610139A (pt) 1999-02-02
BG63720B1 (bg) 2002-10-31
AU705956B2 (en) 1999-06-03
AU6929596A (en) 1997-03-27
WO1997009294A1 (de) 1997-03-13
SI0862550T1 (en) 2001-02-28
CN1070841C (zh) 2001-09-12
NO981002L (no) 1998-03-09
EP0862550A1 (de) 1998-09-09
TR199800410T1 (xx) 1998-05-21
AR003532A1 (es) 1998-08-05
NZ316940A (en) 1999-01-28
JPH11512104A (ja) 1999-10-19
EP0862550B1 (de) 2000-11-08
HUP9802329A3 (en) 1999-04-28
MX9801698A (es) 1998-05-31
NO310651B1 (no) 2001-08-06
US6004988A (en) 1999-12-21
SK28298A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
UA6340A1 (uk) Спосіб одержання заміщених діазабіціклоалкілхінолон карбонових кислот мостиковим зв'язком або їх фармацевтично прийнятних адитивний солей
BR9506815A (pt) Compostos de oxazol aromáticos heterociclicos e o uso dos mesmos
HUP9802329A2 (hu) Karbonsavszármazékok
HUP9802705A2 (hu) Aromás vegyületek, eljárás előállításukra és az azokat tartalmazó gyógyászati készítmények
DE69431691D1 (de) Cephalosporin-Derivate
AU571244B2 (en) Tetrazoles & phenoxyalkanoic acids are leukotriene antagonists
AU4889090A (en) Tetrahydrobenzimidazole derivatives
WO1999000373A8 (fr) Derives de benzimidazole
JPS5220836A (en) Electrophotographic light sensitive material
ES2027898A6 (es) Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
DE60004672D1 (de) Matte pulverbeschichtungszusammensetzung
AU4314000A (en) Heterocyclic carboxylic acid derivatives
HUP0300020A2 (en) Novel compounds
ES8800950A1 (es) Un metodo para preparar nuevos derivados de cefem
IE43711L (en) N-propargyl-2-phenylamino-2-imidazolines
EP1142880A4 (en) BENZIMIDAZOLE DERIVATIVES
JPS55139359A (en) Tetrahydrophthalimides, and herbicide containing compound as effective component
IE43620L (en) N-aralkyl-2-amino-propanamides, antidepressants
IE45692L (en) 1-amino-2-hydroxy-3-heterocyclyloxypropanes.
ATE284686T1 (de) Verbesserte freisetzung von ibuprofen aus heissschmelzklebemassen durch zusatz von pharmazeutischen hilfsstoffen
EP1028118A4 (en) METHOD FOR PRODUCING 3-CEPHEM COMPOUNDS
GB2008586A (en) Benzazepines
NO974958D0 (no) Ny fremgangsmåte for fremstilling av (-)-trans-N-p-fluorbenzoylmetyl-4-(p-fluorfenyl)-3-[[3,4-(metylendioksy)-fenoksy]metyl]-piperidin
AU510569B2 (en) Polymorphic "B" of 4-(2-thenoyl)-2, 3-dichlorophenoxy acetic acid
JPS5690067A (en) Novel heterocyclic ring substituted phenylacetic acid derivative